These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4008377)

  • 21. Cross resistance to ciprofloxacin and other antimicrobial agents among clinical isolates of Acinetobacter calcoaceticus biovar anitratus.
    Shalit I; Dan M; Gutman R; Gorea A; Berger SA
    Antimicrob Agents Chemother; 1990 Mar; 34(3):494-5. PubMed ID: 2185692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of Acinetobacter species to various antimicrobial agents.
    Rolston KV; Bodey GP
    Antimicrob Agents Chemother; 1986 Nov; 30(5):769-70. PubMed ID: 3800353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concerning the sensitivity of Acinetobacter calcoaceticus.
    Jedlicková Z; Tesaríková E; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(1):73-6. PubMed ID: 2351822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of reduced tigecycline susceptibility on clinical outcomes of Acinetobacter bacteremia.
    Chang YY; Liu YM; Liu CP; Kuo SC; Chen TL;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):148-152. PubMed ID: 29050749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of Acinetobacter calcoaceticus var. anitratus (Herellea vaginicola) to minocycline.
    Montgomerie JZ; Pickett MJ; Yoshimori RN; Chow AW; Guze LB
    Antimicrob Agents Chemother; 1976 Jul; 10(1):102-5. PubMed ID: 791084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Problem of treatment for pyo-inflammatory complications caused by Acinetobacter].
    Bogomolova NS; Bol'shakov LV; Kuznetsova SM
    Anesteziol Reanimatol; 2014; (1):26-32. PubMed ID: 24749305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro synergism between carbenicillin and aminoglycosidic aminocyclitols against Acinetobacter calcoaceticus var. anitratus.
    Glew RH; Moellering RC; Buettner KR
    Antimicrob Agents Chemother; 1977 Jun; 11(6):1036-41. PubMed ID: 879749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibacterial activity of aminoglycosides against nosocomial strains of Acinetobacter baumannii isolated between 1990 and 1999].
    González G; Ramírez C; Muñoz M
    Rev Esp Quimioter; 2000 Dec; 13(4):401-4. PubMed ID: 11498707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776].
    Joly-Guillou ML; Serieys C; Verin-Prevost C; Bergogne-Berezin E
    Pathol Biol (Paris); 1983 May; 31(5):392-5. PubMed ID: 6353329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.
    Eser OK; Ergin A; Tunçkanat F; Hasçelik G
    New Microbiol; 2008 Oct; 31(4):535-42. PubMed ID: 19123310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
    Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P
    J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.
    Cunha BA; Baron J; Cunha CB
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):15-20. PubMed ID: 28819873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of norfloxacin in enteric and urinary tract infections: combined effect of norfloxacin with aminoglycosides, tetracycline and chloramphenicol.
    Mascellino MT; Lorenzi A; Bonanni M; Iegri F
    Drugs Exp Clin Res; 1986; 12(4):319-23. PubMed ID: 3720519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein fingerprinting for the determination of relatedness in Acinetobacter calcoaceticus subspecies anitratus isolated from patients in a surgical intensive care unit.
    Mortensen JE; LaRocco MT; Steiner B; Ribner B
    Infect Control; 1987 Dec; 8(12):512-5. PubMed ID: 3429162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective.
    Curcio D; Fernández F
    J Antimicrob Chemother; 2007 Aug; 60(2):449-50. PubMed ID: 17561503
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice.
    Obana Y
    Microbiol Immunol; 1986; 30(7):645-57. PubMed ID: 3773789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic resistance patterns in Acinetobacter spp. strains isolated from hospital environment].
    Văduva DB; Muntean D; Lonescu G; Licker M; Văduva MB; Velimirovici D; Rădulescu M; Dumitraşcu V; Crăciunescu M; Dugăeşescu D; Horhat F; Piluţ C; Bădiţoiu L; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):103-7. PubMed ID: 19856849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The susceptibility to tigecycline of Acinetobacter spp. may vary depending on the methodology used.
    Zárate MS; Serruto G; Smayevsky J
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e351-2. PubMed ID: 20031463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.